Cargando…

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders

OBJECTIVES: Patients with chronic kidney disease (CKD) suffer with multiple comorbidities and complications like secondary hyperparathyroidism and hyperphosphotemia. Altered mineral metabolism contributes to bone disease and cardiovascular disease. In patients of CKD, despite dietary phosphorus rest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajait, Chaitali S, Pimpalkhute, Sonali A, Sontakke, Smita D, Jaiswal, Kavita M, Dawri, Amruta V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912805/ https://www.ncbi.nlm.nih.gov/pubmed/24550582 http://dx.doi.org/10.4103/0253-7613.125163

Ejemplares similares

Evaluation of adherence to therapy in patients of chronic kidney disease
por: Sontakke, Smita, et al.
Publicado: (2015)

Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital
por: Pimpalkhute, Sonali A., et al.
Publicado: (2015)

Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study
por: Kadam, Renuka L., et al.
Publicado: (2020)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
por: Cernaro, Valeria, et al.
Publicado: (2016)

Role of zinc in pediatric diarrhea
por: Bajait, Chaitali, et al.
Publicado: (2011)

Authors’ reply
por: Bajait, Chaitali, et al.
Publicado: (2012)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

The role of kidney transplantation and phosphate binder use in vitamin K status
por: Jansz, Thijs T., et al.
Publicado: (2018)

Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis
por: Chakraborty, Sourav, et al.
Publicado: (2016)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
por: Jaiswal, Swapnil R., et al.
Publicado: (2012)

Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009)

Preparation of acid aluminum phosphate solutions for metakaolin phosphate geopolymer binder
por: Yankwa Djobo, Jean Noël, et al.
Publicado: (2021)

Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
por: Sekercioglu, Nigar, et al.
Publicado: (2016)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014)

Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2023)

Effect of Abdominal Binder on Physiological Cost Index in Chronic Obstructive Pulmonary Disease
por: Kadam, Chaitali, et al.
Publicado: (2021)

Tolerability and efficacy of the intestinal phosphate binder Lantharenol(® )in cats
por: Schmidt, Bernard H, et al.
Publicado: (2012)

The demise of calcium-based phosphate binders—is this appropriate for children?
por: Rees, Lesley, et al.
Publicado: (2014)

Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Phosphate binders in dialysis: better satisfied than sorry
por: Cozzolino, Mario, et al.
Publicado: (2021)

Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go
por: Rizk, Rana
Publicado: (2016)

Impact of medicine-related information on medicine purchase and use by literate consumers
por: Thawani, Vijay R., et al.
Publicado: (2014)

Pre and post-interventional pattern of self medication in three common illnesses in staff of a tertiary hospital
por: Bang, S, et al.
Publicado: (2011)

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
por: Akizawa, Tadao, et al.
Publicado: (2021)

Anemia of Inflammation with An Emphasis on Chronic Kidney Disease
por: Begum, Sajidah, et al.
Publicado: (2019)

Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
por: Gupta, Ajay
Publicado: (2014)

Research on preparation of phosphate-modified animal glue binder for foundry use
por: Wang, Tian-Shu, et al.
Publicado: (2018)

Interventional study to improve adherence to phosphate binder treatment in dialysis patients
por: Hjemås, Bodil Jahren, et al.
Publicado: (2019)

Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
por: Nitta, Kosaku, et al.
Publicado: (2023)

Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
por: Thet, Zaw, et al.
Publicado: (2013)

Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study
por: Schumacher, Stefan P, et al.
Publicado: (2018)

Systematic review and meta-analysis of medicine use studies in Ethiopia using the WHO patient care indicators with an emphasis on the availability of prescribed medicines
por: Teni, Fitsum Sebsibe, et al.
Publicado: (2022)

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study
por: McCullough, Keith, et al.
Publicado: (2021)

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2020)

Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
por: Pepper, Ruth, et al.
Publicado: (2011)

Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study
por: Neradova, A., et al.
Publicado: (2017)

Provider Attitudes and Support of Patients’ Autonomy for Phosphate Binder Medication Adherence in ESRD
por: Umeukeje, Ebele M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nheo7s25drvk3o0omgl33iolea